CLDX
Celldex Therapeutics, Inc.
$39.93
+1.98 (+5.22%)
At close · Jul 7
Market Cap
$3.13B
Shares
78,492,072
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.55M
-78%
FY2025
Net Income
-$258.76M
-63.9%
FY2025
Gross Margin
87.06%
-10.1pp
FY2025
Operating Margin
-18599.81%
-15820.9pp
FY2025
Diluted EPS
-$3.90
-59.2%
FY2025
Operating Cash Flow
-$210.95M
-33.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $1.55M | $7.02M | $6.88M | $2.36M | $4.65M | $7.42M | $3.57M | $9.54M | $12.74M | $6.79M | $5.48M | $3.59M | $4.11M | $11.2M | $9.27M | $46.79M | $15.18M | |
| — | $200K | $200K | $300K | $100K | $100K | $200K | $100K | $700K | $700K | $1.6M | — | — | — | — | — | — | — | |
| — | $1.35M | $6.82M | $6.58M | $2.26M | $4.55M | $7.22M | $3.47M | $8.84M | $12.04M | $5.19M | — | — | — | — | — | — | — | |
| — | 87.06% | 97.15% | 95.64% | 95.76% | 97.85% | 97.3% | 97.2% | 92.66% | 94.51% | 76.42% | — | — | — | — | — | — | — | |
| $265.46M | $245.07M | $163.55M | $118.01M | $82.26M | $53.31M | $42.53M | $42.67M | $66.45M | $96.17M | $102.73M | $100.17M | $104.38M | $67.4M | $47.4M | $32.44M | $27.65M | $26.17M | |
| $44.47M | $43.84M | $38.55M | $30.91M | $27.2M | $20.49M | $14.46M | $15.43M | $19.27M | $25M | $35.98M | $33.84M | $20.62M | $14.81M | $10.02M | $9.19M | $10.38M | $17.12M | |
| — | — | — | — | — | — | $0 | $0 | $224K | $896K | $997K | $1.01M | $1.01M | $1.01M | $1.09M | $1.91M | $3.14M | $949K | |
| — | $3.38M | $3.18M | $3.01M | $2.9M | $3.07M | $3.93M | $4.86M | $3.58M | $4.41M | $3.1M | $3M | $2.39M | $1.93M | $2.05M | $2.25M | $2.72M | $2.58M | |
| $309.93M | $288.91M | $202.1M | $161.43M | $117.59M | $75.89M | $70.77M | $58.6M | $165.97M | $134.27M | $139.7M | $135.02M | $126.02M | $85.55M | $69.28M | $52.66M | $53.25M | $52.03M | |
| -$309.06M | -$287.37M | -$195.08M | -$154.54M | -$115.23M | -$71.24M | -$63.35M | -$55.03M | -$156.44M | -$121.53M | -$132.92M | -$129.54M | -$122.43M | -$81.44M | -$58.08M | -$43.4M | -$6.46M | -$36.85M | |
| — | -18599.81% | -2778.89% | -2245.27% | -4889.01% | -1531.78% | -854.06% | -1540.19% | -1640.13% | -953.68% | -1958.68% | -2363.89% | -3414.11% | -1981.08% | -518.45% | -468.42% | -13.79% | -242.75% | |
| — | -$283.99M | -$191.9M | -$151.53M | -$112.34M | -$68.18M | -$59.43M | -$50.17M | -$152.86M | -$117.11M | -$129.82M | -$126.54M | -$120.04M | -$79.51M | -$56.03M | -$41.15M | -$3.74M | -$34.27M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $927K | $1.58M | $1.8M | $1.34M | $452K | |
| $525K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $396K | $5.26M | $248K | |
| — | -$258.76M | -$157.86M | -$141.43M | -$112.33M | -$70.74M | -$60.95M | -$50.88M | -$151.95M | -$117.31M | -$128.53M | -$127.2M | — | — | — | -$44.8M | -$2.53M | -$37.05M | |
| — | $0 | $0 | $0 | — | -$227K | -$1.17M | — | -$765K | -$24.28M | — | — | — | $0 | $0 | — | — | -$529K | |
| -$283.65M | -$258.76M | -$157.86M | -$141.43M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -16748.03% | -2248.76% | -2054.76% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$258.76M | -$157.86M | -$141.43M | -$112.33M | -$70.51M | -$59.78M | -$50.88M | -$151.18M | -$93.03M | -$128.53M | -$127.2M | -$118.08M | -$81.55M | -$59.12M | -$44.8M | -$2.53M | -$36.53M | |
| -$284.69M | -$258.45M | -$157.86M | -$139.38M | -$112.96M | -$71.21M | -$59.81M | -$50.84M | -$151.17M | -$93.01M | -$128.3M | -$127.48M | -$118.16M | -$81.63M | -$59.03M | -$44.9M | -$2.33M | -$36.59M | |
| USD/shares | — | -$3.90 | -$2.45 | -$2.92 | -$2.40 | -$1.64 | -$2.02 | -$3.51 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$3.90 | -$2.45 | -$2.92 | -$2.40 | -$1.64 | -$2.02 | -$3.51 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 66.42M | 64.4M | 48.45M | 46.89K | 42.87K | 29.64K | 14.51K | 10.44K | 8.57M | 6.77M | 97.05M | 89.4M | 79.78M | 57.71M | 39.5M | 31.87M | 19.82M |
| shares | — | 66.42M | 64.4M | 48.45M | 46.89K | 42.87K | 29.64K | 14.51K | 10.44K | 8.57M | 6.77M | 97.05M | 89.4M | 79.78M | 57.71M | 39.5M | 31.87M | 19.82M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Grant | $1,448,000 | $7,007,000 | $6,605,000 | $2,301,000 | $4,620,000 | $5,117,000 | $3,100,000 |
| Service | $97,000 | $13,000 | $278,000 | $56,000 | $31,000 | $2,301,000 | $473,000 |